Certified by Founder Lodge
Trinity Innovation Fund
China - Beijing
INVESTOR
1 Disclosed Funding Rounds $38,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 2018, Trinity Innovation Fund (TIF) is dedicated to investing on biomedical innovations. Currently we are managing two funds with different focuses. Our limited partners (LPs) incl
| Company | Date | Round | Raised |
|---|---|---|---|
Adcentrx Therapeutics |
April, 25 ,2023 | Series A | $38,000,000 |
Adcentrx Therapeutics
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)